Artificial intelligence accelerates biomedical research while narrowing the scope of scientific exploration, according to a recent analysis of 41 million research papers published in Nature and highlighted by immunologist Eric Vivier. Researchers integrating AI into their workflows publish three times more articles, gather five times more citations, and secure leadership roles a year and a half faster than peers, but the global diversity of scientific topics has contracted by nearly 5 percent in AI-dominated fields.
The Acceleration of Biological Knowledge and Single-Cell Sequencing
Modern biomedical science is advancing at an unprecedented speed due to the convergence of digital tools and deep knowledge of living organisms, according to Eric Vivier, president of the Paris Saclay Cancer Cluster. Vivier coauthored the book Ces nouvelles découvertes qui nous guérissent alongside Florence Sabatier, director of the cell culture and therapy laboratory at Assistance Publique – Hôpitaux de Marseille. The 349-page volume, published by Odile Jacob for 24.90 euros, examines ten major medical breakthroughs, including monoclonal antibodies, CAR-T cells, cellular therapies, messenger RNA vaccines, and genome editing.
The most defining technical revolution in contemporary biology is single-cell sequencing, known as single cell. This technique allows researchers to take a tissue sample and examine the genome of every individual cell within it, analyzing the expression of 23,000 genes simultaneously. Mathematicians and artificial intelligence assist biologists in sorting through this massive volume of data, revealing how individual cells function, interact, and differ despite sharing identical DNA.
Messenger RNA Applications and 3D Bio-Printing Innovations
Beyond data sequencing, scientists now use RNA to instruct human cells to manufacture custom proteins on demand. Covid-19 vaccines proved this capability by delivering an RNA code that prompted cells to generate an immune response rather than injecting a viral fragment. This delivery relies on liponanoparticles—minute fat droplets composed of four lipids outfitted with antibody tags that function like a GPS to target specific cells.
While full organ manufacturing remains limited by the challenge of vascularizing printed tissues with operational blood vessels, cellular therapies are advancing rapidly. More than 70 clinical trials are underway targeting type 1 diabetes, retinal diseases, and heart conditions. In February, Japan granted conditional approval to two cellular therapy products: dopamine-producing neuron precursors for Parkinson’s disease and cardiac cell patches for severe heart failure.
The Indispensable Value of Fundamental Scientific Curiosity
None of these modern medical applications were planned in advance by their inventors, Vivier emphasized. Emmanuelle Charpentier and Jennifer Doudna discovered CRISPR simply by investigating how bacteria defend themselves against virus attacks, earning a Nobel Prize. Similarly, Marcel Dorée and colleagues in Montpellier studied starfish eggs merely to understand why and how cells multiply, laying foundational groundwork for cancer treatments targeting cell division mechanisms.
Vivier argues that research cannot be guided strictly by its applications, comparing the process to the invention of electricity, which did not stem from efforts to improve the candle.
How Artificial Intelligence Shrinks the Scope of Scientific Exploration
While AI tools like AlphaFold accurately predict protein structures from genetic codes and accelerate daily literature reviews, Vivier warns that automation threatens researcher creativity. Data from a January study of 41 million scientific articles published in Nature shows that AI-assisted researchers concentrate on data-rich fields and well-mapped problems. As a result, global scientific exploration has contracted by nearly 5 percent in areas dominated by machine learning.
AI excels at solving known equations rather than exploring unknown frontiers, leading the academic community toward popular topics while neglecting foundational questions that lack historical data. True breakthroughs historically emerge from the unknown territories that human curiosity compels scientists to investigate.
